Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114736206B reveals metal-free aqueous synthesis for quinazolinones. Achieve cost reduction and supply chain reliability with green radical cyclization technology.
Patent CN112661719B details a calcium nitrite-based route for aminothiazolyloxime, reducing wastewater and enhancing supply chain reliability for cephalosporin manufacturers.
Patent CN103524439B details a novel anastrozole synthesis improving purity and yield. Offers supply chain reliability and cost reduction for pharmaceutical manufacturing partners.
Patent CN109136298B reveals a dual-enzyme membrane separation process for D-amino acids, offering >99.9% e.e. and scalable green manufacturing solutions.
Novel patent CN118724858B reveals high-yield synthesis. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing for global buyers.
Novel base-first hydrolysis route for Atorvastatin Calcium ensures >90% yield and high purity, offering significant cost reduction in API manufacturing.
Patent CN104177336A details efficient asymmetric oxidation for Dexlansoprazole. Achieve high optical purity and cost reduction in pharma manufacturing.
Patent CN106478684B reveals novel copper complex synthesis. Delivers high-purity pharmaceutical intermediates with significant supply chain and cost advantages for global buyers.
Patent CN104557583A reveals green quinidine catalysis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability.
Patent CN106928136B details graphene palladium cobalt catalysis for montelukast intermediate. Offers high yield and chiral selectivity for reliable pharmaceutical intermediate supply chains.
Patent CN103319358B details a novel route for 7-aminoheptanoic acid. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing.
Novel synthesis patent CN118666668A offers high purity above 99% and scalable purification for pharmaceutical intermediates supply chain stability and cost efficiency in global manufacturing.
Novel diazotization route ensures high purity pyridine-3-sulfonyl chloride. Reduces waste and enhances supply chain stability for pharmaceutical manufacturing.
Advanced synthesis of 1,3,2'-N,N,N-triacetyl gentamicin C1a via patent CN111040007A. Offers high-purity API intermediates with optimized cost reduction in pharmaceutical manufacturing.
Novel synthesis route for Isepamicin sulfate using Gentamicin B reduces cost and simplifies operation for pharmaceutical manufacturing supply chains globally.
Patent CN100503590C details a novel Rh-catalyzed hydrogenation of L-malic acid diester. This method offers high optical purity and lower pressure conditions for efficient API intermediate manufacturing.
Patent CN114315627B introduces a green ionic liquid-zeolite method for doxycycline intermediates, offering high purity and reduced environmental impact for pharma supply chains.
Advanced synthesis of N-3-isoxazole carbamic acid tert-butyl ester via patent CN109369553B. Delivers high purity, scalable production, and cost-effective supply chain solutions.
Discover the novel preparation method for 16 beta alkyl steroids via CN107746420B. Achieve superior selectivity and yield for pharmaceutical intermediates with reduced costs.
Patent CN112574285B reveals a novel solid-liquid phase synthesis for disulfide-bonded polypeptides, offering high purity and simplified manufacturing for pharmaceutical intermediates.